We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$976M
1-Year Est. Return
66.76%
This Fund
S&P 500
This Quarter
Est. Return
+29.1%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$976M
AUM Growth
+$65.1M
(+7.2%)
Cap. Flow
+$24.5M
Cap. Flow
% of AUM
2.51%
Top 10 Holdings %
Top 10 Hldgs %
37.09%
Holding
100
New
33
Increased
11
Reduced
19
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GRAL
GRAIL Inc
GRAL
|
+$20M |
| 2 |
Fluence Energy
FLNC
|
+$16.7M |
| 3 |
Intuitive Surgical
ISRG
|
+$16.2M |
| 4 |
Hims & Hers Health
HIMS
|
+$14.6M |
| 5 |
Illumina
ILMN
|
+$14.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLNO
Soleno Therapeutics
SLNO
|
+$19.3M |
| 2 |
iShares MSCI South Korea ETF
EWY
|
+$13.2M |
| 3 |
iShares Global Clean Energy ETF
ICLN
|
+$12.8M |
| 4 |
Icon
ICLR
|
+$11.7M |
| 5 |
Sportradar
SRAD
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.52% |
| 2 | Miscellaneous | 25.09% |
| 3 | Technology | 18.45% |
| 4 | Industrials | 16.44% |
| 5 | Consumer Discretionary | 6.87% |
Similar funds
PHP
ACM
FM
PFGIA
PAMI
SI
ZI
RIA
Kingdon Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Kingdon Capital Management held 100 positions worth $976M, up 7.2% from $911M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Kingdon Capital Management's Q2 2026 filing shows 33 new, 11 increased, 19 reduced and 26 closed positions. Its largest new stake was GRAIL Inc: 340,000 shares worth $23.2M. The largest sale was Soleno Therapeutics, an estimated $19.3M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Technology.
- Kingdon Capital Management's largest Q2 2026 buy was GRAIL Inc: 340,000 shares worth $23.2M.
- Kingdon Capital Management added most to NVIDIA in Q2 2026, an estimated $8.22M increase.
- Kingdon Capital Management's biggest Q2 2026 reduction was Flex, cutting an estimated $10.3M.
- Kingdon Capital Management fully exited Soleno Therapeutics in Q2 2026, selling an estimated $19.3M.
- Kingdon Capital Management's ten largest holdings make up 37% of its $976M portfolio in Q2 2026.
- Kingdon Capital Management opened 33 new positions and closed 26 in Q2 2026.
- Kingdon Capital Management's portfolio value rose 7.2% quarter-over-quarter to $976M.
Based on Kingdon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.